Drug Trial Radar · NCT06782334
AMT-116 in Patients with Solid Tumors
Last checked: Nov 19, 2026Latest source record: Jan 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
144
Planned (sponsor's estimate)
Start
May 7, 2024
Primary completion
Jun 30, 2026
Study completion Dec 30, 2026
Sponsor
- Lead sponsor
- Multitude Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of AMT-116 monotherapy in subjects with advanced solid tumors. The study is divided into two parts: the part I is dose escalation and the Part Ⅱ for expansion.
Conditions
- Advanced Solid Tumors
Interventions
AMT-116Drug
AMT-116 is an antibody Drug Conjugate (ADC)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase I: Maximum Tolerated Dose(MTD) and the Recommended Phase 2 Dose(RP2D) of AMT-116Time frame: approximately 12 months
- Phase I: Type, incidence and severity of Adverse Events,Dose Limiting Toxicities (DLTs)Time frame: approximately 12 months
- Phase II: Objective Response Rate(ORR)Time frame: approximately 18 months
- Phase II: Type, incidence and severity of Adverse EventsTime frame: approximately 18 months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Dongguan People's Hospital
Dongguan, Guangdong, China · Not yet recruiting
Zhujiang Hospital of Southern Medical University(The Second Clinical Medical College)
Guangzhou, Guangdong, China · Recruiting
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Zhejiang cancer hospital
Hangzhou, Zhejiang, China · Recruiting
The Second Affiliated Hospital and Yuying Childrens Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.